daprodustat 2 MG Oral Tablet [Jesduvroq]
- RxCUI
- 2628225
- RxNorm name
- daprodustat 2 MG Oral Tablet [Jesduvroq]
- Display name
- daprodustat 2 MG Oral Tablet [Jesduvroq]
- Full name
- daprodustat 2 MG Oral Tablet [Jesduvroq]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jesduvroq | DAPRODUSTAT | GlaxoSmithKline LLC | d82aa06e-5a33-4844-99b7-4701313455a4 | 2023-08-30 | Boxed warning, Warnings, Adverse reactions | 2628225 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d82aa06e-5a33-4844-99b7-4701313455a4 | daprodustat 2 MG Oral Tablet [Jesduvroq] | SBD | 5 | These highlights do not include all the information needed to use JESDUVROQ safely and effectively. See full prescribing information for JESDUVROQ. JESDUVROQ (daprodustat) tablets, for oral use Initial U.S. Approval: 2023 | 20230830 |
| d82aa06e-5a33-4844-99b7-4701313455a4 | Jesduvroq 2 MG Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use JESDUVROQ safely and effectively. See full prescribing information for JESDUVROQ. JESDUVROQ (daprodustat) tablets, for oral use Initial U.S. Approval: 2023 | 20230830 |
| d82aa06e-5a33-4844-99b7-4701313455a4 | Jesduvroq 2 MG Oral Tablet | SY | 5 | These highlights do not include all the information needed to use JESDUVROQ safely and effectively. See full prescribing information for JESDUVROQ. JESDUVROQ (daprodustat) tablets, for oral use Initial U.S. Approval: 2023 | 20230830 |